FOMDWebPartPage

2013 Publications

1.      Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, et al. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am J Transplant 2013;13(9):2352-63. (clinicaltrials.gov NCT01299168)

2.      Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am J Transplant 2013;13(11):2865-74. (clinicaltrials.gov NCT01299168)

3.      Sellares J, Reeve J, Loupy A, Mengel M, Sis B, Skene A, et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 2013;13(4):971-83.

4.      Reeve J, Sellares J, Mengel M, Sis B, Skene A, Hidalgo L, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 2013;13(3):645-55.

5.      Famulski KS, Reeve J, de Freitas DG, Kreepala C, Chang J, Halloran PF. Kidney transplants with progressing chronic kidney diseases express high levels of acute kidney injury transcripts. Am J Transplant 2013;13(3):634-44.

6.      Kreepala C, Famulski KS, Chang J, Halloran PF. Comparing molecular assessment of implantation biopsies with histologic and demographic risk assessment. Am J Transplant 2013 Jan 2;13(2):415-26.

7.      Halloran PF. Transplantation: Autoantibodies-epiphenomena or biological clues. Nature Reviews Nephrology 2013;9(12):705-6.